Home
|Insights
|Re. summary proceedings and biosimilar pharmaceuticals: "Biosimilars en Belgische octrooigeschillen (zoals) in kort geding: een geïnformeerd magistraat is meer waard," IRDI

PDF Link

Re. summary proceedings and biosimilar pharmaceuticals: "Biosimilars en Belgische octrooigeschillen (zoals) in kort geding: een geïnformeerd magistraat is meer waard," IRDI

Publication | 09.01.13

Attachments

Download Attachment
Biosimilars And Belgian Patent Disputes

Contacts

Jan-Diederik Lindemans
Partner
- Brussels
  - D | +32.2.282.1832
amxpbmRlbWFuc0Bjcm93ZWxsLmNvbQ==

Insights

Publication | 06.11.26

Tips For Litigating Life Sciences Investigations At The ITC

Publication | 06.09.26
A Look At The Court's Next Steps In Live Nation Antitrust Case
Publication | 06.08.26
The Rise of Arbitration in Insurance Coverage Disputes: Implications for Coverage Predictability and Policyholder Rights
Publication | 06.05.26
Which employee is still willing to make an extra effort if their colleague who cuts corners earns the same?

View All Insights

Subscribe

to the latest insights from our team